7583-27-9

Usage

Uses

Used in Pharmaceutical Industry:
4,4'-DIIODO-3,3'-DIMETHYLBIPHENYL is used as a building block for the synthesis of pharmaceutical and biologically active compounds. Its unique molecular structure allows for the creation of a wide range of molecules with potential therapeutic applications, making it a valuable component in the development of new drugs.
Used in Chemical Research:
In addition to its pharmaceutical applications, 4,4'-DIIODO-3,3'-DIMETHYLBIPHENYL is also used as a starting material in chemical research. Its distinct structure makes it an interesting candidate for studying various chemical reactions and properties, contributing to the advancement of scientific knowledge in the field of organic chemistry.

Upstream product

• 88-72-2 1-methyl-2-nitrobenzene 
• 617-22-1 2,2'-dimethylhydrazobenzene 
• 119-93-7 o-tolidin 
• 84-67-3 2,2'-dimethylbenzidine 
• 612-75-9 3,3'-dimethyl-biphenyl 

Downstream Products

• 848465-74-7 N,N'-bis[4'-(diphenylamino)biphenyl-4-yl]-N,N'-diphenyl-3,3'-dimethylbiphenyl-4,4'-diamine 
• 167218-55-5 N,N,N',N'-tetrakis(biphenyl-4-yl)-3,3'-dimethyl-4,4'-diaminobiphenyl 
• 134190-10-6 4,4'-bis{(biphenyl-4-yl)-phenylamino}-3,3'-dimethylbiphenyl 
• 1048371-94-3 3,3'-dimethyl-4,4'-bis(triphenylsilyl)biphenyl 
• 223462-90-6 C₅₆H₅₀O 
• 223462-88-2 4-methoxy-2',2'',2''',2'''',2''''',3''''''-hexamethyl-[1,1';4',4'';1'',1''';4''',4'''';1'''',1''''';4''''',1'''''']septiphenyl 

Relevant academic research and scientific papers

PRODUCTION METHOD OF 4,4'-DIIODO-3,3'-DIMETHYLBIPHENYL

PROBLEM TO BE SOLVED: To provide a production method of 4,4'-diiodo-3,3'-dimethylbiphenyl, which is industrially excellent with high production efficiency and without using highly-toxic raw material. SOLUTION: Provided ia a production method of 4,4'-diiodo-3,3'-dimethylbiphenyl by reacting 3,3'-dimethylbiphenyl with an iodinated agent, comprising the steps of: subjecting 4,4'-diiodo-3,3'-dimethylbiphenyl to reactive crystallization in a reaction liquid; and subjecting deposited 4,4'-diiodo-3,3'-dimethylbiphenyl to solid-liquid separation. SELECTED DRAWING: None COPYRIGHT: (C)2019,JPOandINPIT

Synthetic method for 4,4'-dihalogenated-3,3'-dialkyl(alkoxyl) biphenyl compounds

The invention relates to a synthetic method for 4,4'-dihalogenated-3,3'-dialkyl(alkoxyl) biphenyl compounds. The method employs o-nitro alkyl (alkoxyl) benzene as an initial raw material, 2,2'-dialkyl(alkoxyl) hydrazobenzene is prepared through catalysis hydrogenation in an alkaline environment, hydrochloric acid acidifying rearrangement is carried out, 4,4'-diamino-3,3'-dialkyl(alkoxyl) biphenyl is prepared, finally, a diazotization reaction is carried out and 4,4'-dihalogenated-3,3'-dialkyl(alkoxyl) biphenyl compounds are prepared. The synthetic method is advantaged by cheap and easily available raw materials, mild reaction conditions, simple operation, high safety coefficient, high yield and low cost.

Efficient, Scalable Syntheses of Linker Molecules for Metal-Organic Frameworks

Efficient synthesis protocols for five linkers of immediate interest for use in metal-organic frameworks (MOFs) are presented. The importance of scalable, cost-effective, high-yield processes with simple purifications and few steps is emphasized. The prot

USE OF A POROUS CRYSTALLINE HYBRID SOLID AS A NITROGEN OXIDE REDUCTION CATALYST AND DEVICES

The present invention relates to the use of solids consisting of a metal-organic framework (MOF) and having the units of the following formula (I): MmOkXILp as a nitrogen-oxide catalyst. The present invention also relates to devices for enabling the implementation of said use. The nitrogen oxides in question are nitrogen monoxide and nitrogen dioxide, collectively referred to as NOx. The MOF solids of the present invention are advantageously capable of removing nitrogen oxides from a liquid or gaseous effluent, for example from water, from the exhaust gases of a vehicle, factory, workshop, laboratory, stored products, urban air vents, etc., without any reducing agent and at a low temperature. The DeNOx catalysis is a major issue for our societies. The invention can be used for reducing or even avoiding the consequences for public health of the toxic NOx gases resulting from human activity.

POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST

The invention relates to solids made of a porous crystalline metal-organic framework (MOF) loaded with at least one gas of biological interest, and to a method for preparing the same. The MOF solids of the present invention are capable of adsorbing and releasing in a controlled manner gases having a biological interest. They can be used in the pharmaceutical field and/or for applications in the cosmetic field. They can also be used in the food industry.

REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS

The present invention relates to reducible porous crystalline solids, constituted of a metal-organic framework (MOF), for the separation of mixtures of molecules having different unsaturation degrees and/or a different number of unsaturations with a selectivity that can be adjusted by controlling the reduction of the MOF. The MOF solids of the present invention, after reduction, have a strong affinity for molecules containing at least one unsaturation. They can be used in various separation processes, especially those relating to hydrocarbons.

SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE

The invention relates to solid organometallic hybrids with modified surface. Said solid may be used for example for the encapsulation and vectoring of molecules of interest such as active pharmaceutical agents, compounds of interest in cosmetics and markers, for example, contrast agents. Said solids show good results in terms of loading capacity in medicament agents and in biocompatibility.

ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES

The invention relates to nanoparticles made from organometallic hybrid materials made from iron carboxylates, used for example as contrast agents. The particles can also be used for the encapsulation and vectoring of molecules of interest such as active3 pharmaceutical agents, cosmetically interesting compounds and markers. Apart from the intrinsic properties thereof for imaging, said nanoparticles give good results in terms of capacity for loading with medicaments and in biocompatibility.